Excess Total Mortality in Italy: An Update to February 2023 with Focus on Working Ages

Authors

  • Gianfranco Alicandro Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
  • Alberto Giovanni Gerli Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy https://orcid.org/0000-0003-4511-6878
  • Stefano Centanni Respiratory Unit, Department of Health Sciences, ASST Santi Paolo e Carlo, Università degli Studi di Milano, Milan, Italy
  • Giuseppe Remuzzi Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Bergamo, Italy
  • Carlo La Vecchia Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy

Keywords:

COVID-19, SARS-CoV-2, pandemic, excess deaths, working age

Abstract

Background: Italy had a persistent excess of total mortality up to July 2022. This study provides updated estimates of excess mortality in Italy until February 2023. Methods: Mortality and population data from 2011 to 2019 were used to estimate the number of expected deaths during the pandemic. Expected deaths were obtained using over-dispersed Poisson regression models, fitted separately for men and women, including calendar year, age group, and a smoothed function of the day of the year as predictors. The excess deaths were then obtained by calculating the difference between observed and expected deaths and were computed at all ages and working ages (25-64 years). Results: We estimated 26,647 excess deaths for all ages and 1248 for working ages from August to December 2022, resulting in a percent excess mortality of 10.2% and 4.7%, respectively. No excess mortality was detected in January and February 2023. Conclusions: Our study indicates substantial excess mortality beyond those directly attributed to COVID-19 during the BA.4 and BA.5 Omicron wave in the latter half of 2022. This excess could be attributed to additional factors, such as the heatwave during the summer of 2022 and the early onset of the influenza season.

References

Islam N. “Excess Deaths” Is the Best Metric for Tracking the Pandemic. BMJ. 2022;376:o285. Doi: 10.1136/bmj.o285

Alicandro G, Remuzzi G, Centanni S, Gerli A, La Vecchia C. Excess total mortality during the Covid-19 pandemic in Italy: updated estimates indicate persistent excess in recent months. Med Lav. 2022;113(2):e2022021. Doi: 10.23749/mdl.v113i2.13108

Alicandro G, Gerli AG, Remuzzi G, Centanni S, La Vecchia C. Updated estimates of excess total mortality in Italy during the circulation of the BA.2 and BA.4-5 Omicron variants: April-July 2022. Med Lav. 2022;113(5):e2022046. Doi: 10.23749/MDL.V113I5.13825

Alicandro G, Remuzzi G, Centanni S, Gerli A, La Vecchia C. No excess mortality among working-age Ital-ians during the Omicron wave of Covid-19. Med Lav. 2022;113(3):e2022030. Doi: 10.23749/MDL.V113I3.13092

Istituto Nazionale di Statistica. Decessi e cause di morte: cosa produce l’Istat. Published 2021. Accessed May 9, 2023. https://www.istat.it/it/archivio/240401

Epicentro - ISS. Monitoraggio delle varianti del virus SARS-CoV-2 di interesse in sanità pubblica in Italia. Https://Www.Epicentro.Iss.It/Coronavirus/Sars-Cov-2-Monitoraggio-Varianti. Published 2021. Ac-cessed May 5, 2023. https://www.epicentro.iss.it/coronavirus/sars-cov-2-monitoraggio-varianti-rapporti-periodici

Khunti K, Aroda VR, Aschner P, et al. The impact of the COVID-19 pandemic on diabetes services: plan-ning for a global recovery. Lancet Diabetes Endocrinol. 2022;10(12):890-900. Doi: 10.1016/S2213-8587(22)00278-9

Carr MJ, Wright AK, Leelarathna L, et al. Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in pri-mary care. BMJ Qual Saf. 2022;31(7):503-514. Doi: 10.1136/bmjqs-2021-013613

Dale CE, Takhar R, Carragher R, et al. The impact of the COVID-19 pandemic on cardiovascular disease prevention and management. Nat Med. 2023;29(1):219-225. Doi: 10.1038/s41591-022-02158-7

Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583-590. Doi: 10.1038/S41591-022-01689-3

Raisi-Estabragh Z, Cooper J, Salih A, et al. Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank. Heart. 2022;109(2):119-126. Doi: 10.1136/heartjnl-2022-321492

Influenza - situazione in Italia - FluNews Italia, rapporto della sorveglianza integrata dell’influenza. Ac-cessed May 8, 2023. https://www.epicentro.iss.it/influenza/flunews#epi

Eurostat. Excess mortality - statistics - Statistics Explained. Eurostat statistics explained. Published 2022. Accessed February 23, 2023. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Excess_mortality_-_statistics#Excess_mortality_in_the_EU_between_January_2020_and_July_2022

Levitt M, Zonta F, Ioannidis JPA. Excess death estimates from multiverse analysis in 2009-2021. Eur J Epidemiol. Published online April 12, 2023. Doi: 10.1007/S10654-023-00998-2

Alicandro G, Remuzzi G, La Vecchia C. Italy's first wave of the COVID-19 pandemic has ended: no excess mortality in May, 2020. Lancet. 2020;396(10253):e27-e28. Doi: 10.1016/S0140-6736(20)31865-1

Downloads

Published

12-06-2023

Issue

Section

Original articles

How to Cite

1.
Alicandro G, Gerli AG, Centanni S, Remuzzi G, La Vecchia C. Excess Total Mortality in Italy: An Update to February 2023 with Focus on Working Ages. Med Lav [Internet]. 2023 Jun. 12 [cited 2025 May 28];114(3):e2023028. Available from: https://mattioli1885journals.com/index.php/lamedicinadellavoro/article/view/14740